1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Imase, Hidetomo,Yamada, Ken,Miyake, Takahiro,Kawanami, Toshio,Ohmori, Osamu,Yasoshima, Kayo,Mogi, Muneto

申请号：

AU2008333272

公开号：

AU2008333272B2

申请日:

2008.12.01

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

The present invention provides a compound of formula (I): wherein the variantsR1, R2, R3, R4, R6, R7 are as defined herein, and wherein said compound is an inhibitorof CETP, and thus can be employed for the treatment of a disorder or disease mediatedby CETP or responsive to the inhibition of CETP.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/